Jason Amello - 03 Jan 2025 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Chief Financial Officer
Signature
/s/ Jason Amello
Issuer symbol
TCRX
Transactions as of
03 Jan 2025
Transactions value $
$0
Form type
4
Filing time
11 Feb 2025, 17:47:29 UTC
Previous filing
02 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (Right to Buy) Award $0 +270K $0.00 270K 03 Jan 2025 Voting Common Stock 270K $3.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.